Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00960037 · ClinicalTrials.gov registry record · NA
Trial to Assess Response to Oral Vitamin D3 Supplementation in Obese Individuals
A NA study, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT00960037: Completed NA study, sponsored by Winthrop University Hospital.
NCT00960037 is a NA study that has completed, run by Winthrop University Hospital. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00960037, a NA study, has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study is an extension of an earlier study of vitamin D supplementation conducted on normal weight individuals by Dr. John Aloia of the Bone Mineral Research Division at Winthrop University Hospital. The investigators plan to compare the response to vitamin D supplementation in obese individuals with the response already measured in normal weight individuals. The same dosing schedule of vitamin supplementation will be used as in the past. The doses used in the past have demonstrated safety in a number of trials, here at Winthrop as well as outside of Winthrop Hospital. Sixty study volunteers are planned for enrollment in the study. The study participants will mainly be recruited from a group of patients who have in the past been enrolled in the weight loss program at Winthrop Hospital. Each participant will be on vitamin D supplementation for a total of 8 weeks. Vitamin D blood levels will be measured before and at the end of the supplementation period. They will then be compared to see the change over time as a result of supplementation.
Interventions
- DIETARY_SUPPLEMENT Oral vitamin D3
- DIETARY_SUPPLEMENT Placebo equivalent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT00960037 record still lists
NCT00960037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Oral vitamin D3 is the first listed.
NCT00960037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00960037 about?
NCT00960037 is a clinical study titled "Trial to Assess Response to Oral Vitamin D3 Supplementation in Obese Individuals". This study is an extension of an earlier study of vitamin D supplementation conducted on normal weight individuals by Dr. John Aloia of the Bone Mineral Research Division at Winthrop University Hospital. The investigators plan to compare the response to vitamin D supplementation in obese individuals...
What is the current status of trial NCT00960037?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2009-01. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00960037?
The interventions under investigation include: Oral vitamin D3 (DIETARY_SUPPLEMENT), Placebo equivalent (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00960037?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00960037's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia